Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Oral dosage form for propiverine or its pharmaceutically acceptable salts with an extended release of the active ingredient

Oral dosage form for propiverine or its pharmaceutically acceptable salts with an extended release of the active ingredient

US Patent 7943176 · Granted May 17, 2011

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Oxazolidinone-quinolone hybrid antibacterial for the parenteral treatment of pro2022
Oxazolidinone-quinolone hybrid antibacterials for the parenteral treatment or pr2020
Active ingredient containing stabilised solid medicinal forms and methods for th2020
Triazine-intercalated metal phosphates, compositions, and methods2019
Flame retardant composition2019
Active ingredient containing stabilised solid forms and method for the productio2019
Stabilized solid medicinal forms containing active ingredient and method for the2017
Flame protection agent compositions containing triazine intercalated metal phosp2017
Azine metal phosphates as flame-retardant materials2016
Triazine compounds containing phosphorous as flame retardants2016
Use of HDAC and/or DNMT inhibitors for treatment of ischemic injury2016
Solubilized ibuprofen2015